RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/25760630http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/25760630http://www.w3.org/2000/01/rdf-schema#comment"Muscle atrophy F-Box (MAFbx)/atrogin-1 and muscle ring-finger-1 (MuRF-1) have been identified as two muscle-specific E3 ubiquitin ligases that are highly expressed in skeletal muscle during muscle atrophy. However, the role of muscle-specific E3 ubiquitin ligases during the process of muscle atrophy of cancer cachexia remains largely unknown. In the present study, we analyzed the expression of atrogin-1 and MuRF-1 in the skeletal muscle of patients with malignant and benign disease. The possible mechanisms were studied both in a colon 26-induced cancer cachexia mouse model and in tumor necrosis factor-α (TNF-α) induced atrophy C2C12 cells. Our results demonstrated that atrogin-1 and MuRF-1 tended to be increased in the skeletal muscle of patients with malignant disease even before weight loss. Non-tumor body weights and gastrocnemius weights were significantly decreased while expression levels of ubiquitin proteasome pathway associated genes (atrogin-1, MuRF-1, ubiquitin and E2-14K) were upregulated in cancer cachexia mice. Significant myotube atrophy with atrogin-1 overexpression was observed in the C2C12 cells treated with TNF-α. Meanwhile, knockdown of atrogin-1 by small interfering RNA (siRNA) protected C2C12 cells from the adverse effect of TNF-α. In conclusion, muscle-specific E3 ubiquitin ligases were upregulated during cancer cachexia, and atrogin-1 may be a potential molecular target for treating muscle atrophy induced by cancer cachexia."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.org/dc/terms/identifier"doi:10.3892/or.2015.3845"xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Han Y."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Fang J."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Han J."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Jiang Y."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Wu G."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Yuan L."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Zhang B."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Meng Q."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Xi Q."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/author"Zhuang Q."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/date"2015"xsd:gYear
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/name"Oncol Rep"xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/pages"2261-2268"xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/title"Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study."xsd:string
http://purl.uniprot.org/citations/25760630http://purl.uniprot.org/core/volume"33"xsd:string
http://purl.uniprot.org/citations/25760630http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/25760630
http://purl.uniprot.org/citations/25760630http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/25760630
http://purl.uniprot.org/uniprot/#_B9EJZ0-mappedCitation-25760630http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25760630
http://purl.uniprot.org/uniprot/#_F8VPZ1-mappedCitation-25760630http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25760630
http://purl.uniprot.org/uniprot/#_Q38HM4-mappedCitation-25760630http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25760630
http://purl.uniprot.org/uniprot/#_I6L984-mappedCitation-25760630http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25760630
http://purl.uniprot.org/uniprot/#_Q0VAQ6-mappedCitation-25760630http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/25760630